FR10C0045I1 - - Google Patents

Info

Publication number
FR10C0045I1
FR10C0045I1 FR10C0045C FR10C0045I1 FR 10C0045 I1 FR10C0045 I1 FR 10C0045I1 FR 10C0045 C FR10C0045 C FR 10C0045C FR 10C0045 I1 FR10C0045 I1 FR 10C0045I1
Authority
FR
France
Prior art keywords
formula
preparation
sbf5
dibromomethane
vinflunine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR10C0045I1 publication Critical patent/FR10C0045I1/fr
Application granted granted Critical
Publication of FR10C0045I2 publication Critical patent/FR10C0045I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
FR10C0045C 1997-04-10 2010-09-27 Derive halogene antimitotique d'alcaloide de vinca Active FR10C0045I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
EP98920607A EP0975640B1 (fr) 1997-04-10 1998-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
EP20030017052 EP1357125A3 (fr) 1997-04-10 1998-04-10 Procédé de préparation de dérivés halogénés d'alcaloides de vinca

Publications (2)

Publication Number Publication Date
FR10C0045I1 true FR10C0045I1 (OSRAM) 2010-10-29
FR10C0045I2 FR10C0045I2 (fr) 2011-04-29

Family

ID=9505731

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9704398A Expired - Lifetime FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
FR10C0045C Active FR10C0045I2 (fr) 1997-04-10 2010-09-27 Derive halogene antimitotique d'alcaloide de vinca

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9704398A Expired - Lifetime FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Country Status (15)

Country Link
US (1) US6127377A (OSRAM)
EP (3) EP1764368B1 (OSRAM)
JP (3) JP4401440B2 (OSRAM)
AT (2) ATE473987T1 (OSRAM)
AU (1) AU737549C (OSRAM)
BR (2) BR9807944B1 (OSRAM)
CA (3) CA2286560C (OSRAM)
CY (2) CY1111476T1 (OSRAM)
DE (3) DE69841766D1 (OSRAM)
DK (2) DK1764368T3 (OSRAM)
ES (2) ES2347878T3 (OSRAM)
FR (2) FR2761990B1 (OSRAM)
LU (1) LU91769I2 (OSRAM)
PT (2) PT975640E (OSRAM)
WO (1) WO1998045301A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) * 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
JP5448299B2 (ja) * 2003-12-04 2014-03-19 アルバニー モレキュラー リサーチ, インコーポレイテッド ビンカ誘導体
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Birドメイン結合化合物
FR2894966B1 (fr) 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
SG10201407457UA (en) 2006-05-16 2014-12-30 Pharmascience Inc Iap bir domain binding compounds
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) * 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
MX340870B (es) 2010-02-12 2016-07-27 Pharmascience Inc Compuestos de unión del dominio de repetición de inhibidores de proteínas de apoptosis de baculovirus.
EP2539339B1 (en) 2010-02-22 2014-05-14 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
WO2026064527A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload
WO2026064520A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
JP2001518892A (ja) 2001-10-16
ES2222588T3 (es) 2005-02-01
CA2286560C (fr) 2009-09-08
WO1998045301A1 (fr) 1998-10-15
EP0975640B1 (fr) 2004-06-30
LU91769I2 (fr) 2011-02-22
FR10C0045I2 (fr) 2011-04-29
JP4307292B2 (ja) 2009-08-05
CA2455416C (fr) 2010-11-02
ES2347878T3 (es) 2010-11-22
BR9807944A (pt) 2000-03-08
AU737549C (en) 2002-03-28
DK0975640T3 (da) 2004-11-01
CY2010019I1 (el) 2012-01-25
EP1357125A2 (fr) 2003-10-29
ATE473987T1 (de) 2010-07-15
DE122010000054I1 (de) 2011-05-05
ATE270297T1 (de) 2004-07-15
US6127377A (en) 2000-10-03
FR2761990A1 (fr) 1998-10-16
BR9807944B1 (pt) 2011-02-08
DK1764368T3 (da) 2010-10-18
CA2286560A1 (fr) 1998-10-15
CA2665949A1 (fr) 1998-10-15
EP0975640A1 (fr) 2000-02-02
EP1357125A3 (fr) 2003-11-26
DE69824840T2 (de) 2005-07-21
JP2009167196A (ja) 2009-07-30
JP2004277418A (ja) 2004-10-07
CA2455416A1 (fr) 1998-10-15
PT975640E (pt) 2004-11-30
CY1111476T1 (el) 2012-01-25
EP1764368B1 (fr) 2010-07-14
PT1764368E (pt) 2010-09-16
JP4401440B2 (ja) 2010-01-20
CY2010019I2 (el) 2012-01-25
DE69824840D1 (de) 2004-08-05
CA2665949C (fr) 2013-06-11
EP1764368A1 (fr) 2007-03-21
AU737549B2 (en) 2001-08-23
FR2761990B1 (fr) 1999-06-25
AU7340898A (en) 1998-10-30
DE69841766D1 (de) 2010-08-26
BR9816177B1 (pt) 2010-08-24

Similar Documents

Publication Publication Date Title
LU91769I2 (fr) Ditartrate de Vinflunine.
YU208687A (en) Process for obtaining analog of rebecamicine
NZ214653A (en) 6-thioxanthine derivatives and pharmaceutical compositions
ES8405795A1 (es) Procedimiento para la preparacion de derivados de b-carbolina
JPS57109787A (en) Pyrazoloindazole derivative
HUT37431A (en) Process for the production of imidazo /1,2-c/pyrimidines and of their salts,as well as of therapeutic preparations containing these compounds as agent
GR861782B (en) Method for preparing n-methyl derivatives of ergoline
HUT40090A (en) New process for production of derivatives of hh-1,2,4-triasole
JPS57192342A (en) Isoprenylamine derivative
ZA83851B (en) Carbacyclins, process for the preparation thereof, and use thereof as medicinal agents
AU3862985A (en) Perfluoroalkyldichloroethylenes and production of perfluoroalkanecarboxylic acids
EP0127066A3 (en) Composition for treating asthma
JPS57192341A (en) Isoprenylamine derivative
JPS5583766A (en) Isoxazolin-3-one derivative
HUT43066A (en) Process for preparing 2,4-diamino-6-imidazo/1,2-a/pyridyl-1,3,5-triazine derivatives
UA6324A1 (uk) Спосіб одержання похідних 6-фтор-1, дігідро-4-оксо-7-заміщений піперазінілхінолін-3-карбонової кислоти або їх фармацевтично прийнятних солей
JPS51113890A (en) Method for preparing novel cephalosporins
JPS54138600A (en) Benzo-azabicyclo3,3,1-nonane derivative
JPS5745157A (en) Heterocyclic ring compound containing nitrogen
JPS55100384A (en) Cephalosporin analog
JPS54148750A (en) Novel halogenoacetanilide derivative and its preparation
JPS54138574A (en) 1,2,3,4-tetrahydroisoquinoline derivative
JPS51128952A (en) Process for preparing bicyclo (3,1,0) hexane-2-one derivatives
JPS52153995A (en) Pyrrolopyridine derivatives and method of preparing same